Novakand Pharma AB (publ) (STO:NOVKAN)
Sweden · Delayed Price · Currency is SEK 0.0250
-0.0196 (-43.95%)
Inactive · Last trade price on Apr 13, 2026
Novakand Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 16.07 | 46.36 | 45.69 | 95.15 | 106.52 |
Cash & Short-Term Investments | 16.07 | 46.36 | 45.69 | 95.15 | 106.52 |
Cash Growth | -65.33% | 1.47% | -51.98% | -10.68% | 93.65% |
Accounts Receivable | - | - | - | - | 5.28 |
Other Receivables | 0.43 | 1.54 | 1.24 | 0.86 | - |
Receivables | 0.43 | 1.54 | 1.24 | 0.86 | 5.28 |
Prepaid Expenses | 0.23 | 1.01 | 0.71 | 0.97 | - |
Other Current Assets | - | - | - | 2.51 | - |
Total Current Assets | 16.73 | 48.91 | 47.64 | 99.49 | 111.8 |
Property, Plant & Equipment | - | - | - | 0.25 | 0.61 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
Other Intangible Assets | - | 18 | 18 | 21 | 21 |
Other Long-Term Assets | - | - | - | - | -0 |
Total Assets | 16.73 | 66.91 | 65.64 | 120.74 | 133.41 |
Accounts Payable | - | 2.67 | 2.75 | 3.33 | 3.6 |
Accrued Expenses | 0.86 | 1.28 | 14.66 | 6.74 | 6.7 |
Current Portion of Leases | - | - | - | - | 0.13 |
Other Current Liabilities | 0.81 | 0.67 | 0.57 | 3.76 | - |
Total Current Liabilities | 1.67 | 4.61 | 17.98 | 13.83 | 10.43 |
Long-Term Leases | - | - | - | - | 0.44 |
Other Long-Term Liabilities | -0 | - | - | - | -0 |
Total Liabilities | 1.67 | 4.61 | 17.98 | 13.83 | 10.87 |
Common Stock | 11.78 | 11.78 | 7.92 | 66.27 | 46.79 |
Additional Paid-In Capital | 458.82 | 460.92 | 405.57 | 401.58 | 384.21 |
Retained Earnings | -455.54 | -410.4 | -365.83 | -360.94 | -308.46 |
Comprehensive Income & Other | - | - | - | 0 | -0 |
Shareholders' Equity | 15.07 | 62.3 | 47.67 | 106.91 | 122.54 |
Total Liabilities & Equity | 16.73 | 66.91 | 65.64 | 120.74 | 133.41 |
Total Debt | - | - | - | - | 0.57 |
Net Cash (Debt) | 16.07 | 46.36 | 45.69 | 95.15 | 105.95 |
Net Cash Growth | -65.33% | 1.47% | -51.98% | -10.20% | 97.36% |
Net Cash Per Share | 0.13 | 0.40 | 0.57 | 1.64 | 1.89 |
Filing Date Shares Outstanding | 121.19 | 121.19 | 81.51 | 79.53 | 56.14 |
Total Common Shares Outstanding | 121.19 | 121.19 | 81.51 | 79.53 | 56.14 |
Working Capital | 15.06 | 44.3 | 29.66 | 85.66 | 101.37 |
Book Value Per Share | 0.12 | 0.51 | 0.58 | 1.34 | 2.18 |
Tangible Book Value | 15.07 | 44.3 | 29.67 | 85.91 | 101.54 |
Tangible Book Value Per Share | 0.12 | 0.37 | 0.36 | 1.08 | 1.81 |
Machinery | - | - | - | 0.06 | 0.06 |